0000937556-18-000010.txt : 20180202
0000937556-18-000010.hdr.sgml : 20180202
20180202182529
ACCESSION NUMBER: 0000937556-18-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180201
FILED AS OF DATE: 20180202
DATE AS OF CHANGE: 20180202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Yongsam
CENTRAL INDEX KEY: 0001403400
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33642
FILM NUMBER: 18572291
MAIL ADDRESS:
STREET 1: C/O MASIMO CORPORATION
STREET 2: 40 PARKER
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MASIMO CORP
CENTRAL INDEX KEY: 0000937556
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 330368882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-297-7000
MAIL ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wf-form4_151761391433055.xml
FORM 4
X0306
4
2018-02-01
0
0000937556
MASIMO CORP
MASI
0001403400
Lee Yongsam
C/O MASIMO CORPORATION
52 DISCOVERY
IRVINE
CA
92618
0
1
0
0
EVP & CIO
Common Stock
2018-02-01
4
M
0
10000
30.06
A
79000
D
Common Stock
2018-02-01
4
S
0
10000
92.954
D
69000
D
Non-Qualified Stock Option (Right to Buy)
30.06
2018-02-01
4
M
0
10000
30.06
D
2012-02-22
2021-02-22
Common Stock
10000.0
10000
D
The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of August 21, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.39 per share to a high of $93.84 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on February 22, 2011 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
/s/ David J. Van Ramshorst - Attorney-in-Fact
2018-02-02